An inhibitor of CDKs
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

NVP-LCQ195

Item No. 42728

Technical Information
Formal Name
4-[(2,6-dichlorobenzoyl)amino]-N-[1-(methylsulfonyl)-4-piperidinyl]-1H-pyrazole-3-carboxamide
CAS Number
902156-99-4
Synonyms
  • AT-9311
  • LCQ-195
Molecular Formula
C17H19Cl2N5O4S
Formula Weight
Purity
≥98%
A solid
Ethanol: Slightly soluble: 0.1-1 mg/ml
SMILES
O=C(NC1CCN(S(C)(=O)=O)CC1)C2=NNC=C2NC(C3=C(Cl)C=CC=C3Cl)=O
InChi Code
InChI=1S/C17H19Cl2N5O4S/c1-29(27,28)24-7-5-10(6-8-24)21-17(26)15-13(9-20-23-15)22-16(25)14-11(18)3-2-4-12(14)19/h2-4,9-10H,5-8H2,1H3,(H,20,23)(H,21,26)(H,22,25)
InChi Key
CCUXEBOOTMDSAM-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Kinase Resource Center
    Discover Products & Resources for Kinase Research
    • Kinase inhibitors, screening libraries, assay kits, & more
    • Tools to study kinase signaling pathways:
      • Growth factor signaling
      • PI3K/Akt/mTOR
      • MAPKs (ERK, p38, & JNK)
      • JAK/STAT signaling
    • Articles, resources, & advice
    EXPLORE NOW
    Product Description

    NVP-LCQ195 is an inhibitor of cyclin-dependent kinases (CDKs).1 It selectively inhibits Cdk5/p25, Cdk5/p35, Cdk1/cyclin B, Cdk2/cyclin A, and Cdk2/cyclin E complexes (IC50s = 1, 1, 2, 2, and 5 nM, respectively) over Cdk9/cyclin T1, Cdk3/cyclin E, Cdk6/cyclin D3, and Cdk7/cyclin H complexes (IC50s = 15, 42, 187, and 3,564 nM, respectively). NVP-LCQ195 decreases viability in a panel of 25 multiple myeloma cells (EC50s = 0.761-2.81 µM). It induces cell cycle arrest at the G0 phase and apoptosis in MM.1S multiple myeloma cells when used at a concentration of 2 µM.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. McMillin, D.W., Delmore, J., Negri, J., et alMolecular and cellular effects of multi-targeted cyclin-dependent kinase inhibition in myeloma: Biological and clinical implications. Br. J. Haematol. 152(4), 420-432 (2011).